Our studies suggest that targeted elevation of Plp1, which is down-regulated in some studies of AD (170)—or perhaps targeting a number of other activated Xi genes—might improve cognitive deficits in aging and neurodegenerative disease. The gene discussed is PLP1; the disease is Alzheimer disease.